Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Cash and cash equivalents:
Cash and due from banks	$ 4,615	$ 6,564
Interest-bearing balances with banks	606,296	391,665
Total cash and cash equivalents	610,911	398,229
Investment securities available-for-sale	374,828	345,275
Equity securities	41,760	41,086
Loans held-for-sale	0	629
Loans receivable	2,171,272	2,317,594
Allowance for credit losses	(21,499)	(22,124)
Loans receivable, net	2,149,773	2,295,470
Premises and equipment, net	18,838	20,928
Bank-owned life insurance	45,154	44,287
Equity method investments	77,172	75,754
Accrued interest receivable and other assets	100,320	92,224
TOTAL ASSETS	3,418,756	3,313,882
Deposits:
Noninterest-bearing	989,144	1,197,272
Interest-bearing	2,012,504	1,704,204
Total deposits	3,001,648	2,901,476
Accrued interest payable and other liabilities	35,428	37,917
Repurchase agreements	4,755	4,821
Subordinated debt	73,725	73,540
Senior term loan	0	6,786
Total liabilities	3,115,556	3,024,540
STOCKHOLDERS’ EQUITY
Common stock - par value $1; 40,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 13,775,978 and 12,927,962 shares issued and outstanding, respectively, as of September 30, 2024 and 13,606,399 and 12,758,383 shares issued and outstanding, respectively, as of December 31, 2023	13,776	13,606
Additional paid-in capital	163,532	160,488
Retained earnings	164,978	160,862
Accumulated other comprehensive loss	(22,459)	(28,831)
Treasury stock - 848,016 shares as of September 30, 2024 and December 31, 2023, at cost	(16,741)	(16,741)
Total equity attributable to parent	303,086	289,384
Noncontrolling interest	114	(42)
Total stockholders' equity	303,200	289,342
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 3,418,756	$ 3,313,882